Understanding API Manufacturing space in India
01/21/2026
One of our clients wants to connect with experts who have knowledge about API and drug substance manufacturing in India. They are trying to understand the scope of optimizing plant operations with a focus on yield improvement, cost reduction, operational efficiency, and best practices in small molecule manufacturing, CDMO operations, xanthine derivatives, sulphur-based compounds, and sulphonation processes. The experts who have previously worked with prominent players such as Aurobindo Pharma, Divis Laboratories, Laurus Labs, Sun Pharmaceutical Industries, Dr Reddys Laboratories and Cipla etc. would be ideal.
